Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT
Objective: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D). Intervention: A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance tes...
Saved in:
| Published in | International Journal of Obesity Vol. 38; no. 8; pp. 1089 - 1096 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.08.2014
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objective:
To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D).
Intervention:
A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3 kg m
−2
were randomly assigned to intervention and control groups. Intervention consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time.
Results:
Over 80% of the daily steps clustered at an acceleration level of 0.3–0.7 g (2–3 km h
−1
of walking) and were 5870 in the intervention and 4434 in the control group (
P
<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (−3.4 mU l
−1
,
P
=0.035 and −26.6,
P
=0.003, respectively), homeostasis model assessment-estimated insulin resistance (−1.0,
P
=0.036), total cholesterol (−0.55 mmol l
−1
,
P
=0.041), low-density lipoprotein (LDL) cholesterol (−0.36 mmol l
−1
,
P
=0.008) and visceral fat area (−5.5 cm
2
,
P
=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780–2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change.
Conclusion:
Habitual and structured PAs with the acceleration levels of 0.3–0.7 g and daily steps over 6520, equivalent to walking at 2–3 km h
−1
for 90 min daily, standing for the relative PA intensity of 30–35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. |
|---|---|
| AbstractList | OBJECTIVE: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D). INTERVENTION: A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8 ± 10.4 years and body mass index 31.7 ± 5.3 kg [m.sup.-2] were randomly assigned to intervention and control groups. Intervention consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time. RESULTS: Over 80% of the daily steps clustered at an acceleration level of 0.3- 0.7 g (2-3 km [h.sup.- 1] of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4 mU [l.sup.- 1], P = 0.035 and - 26.6, P = 0.003, respectively), homeostasis model assessment-estimated insulin resistance (- 1.0, P = 0.036), total cholesterol(-0.55 mmol [l.sup.- 1], P = 0.041), low-density lipoprotein (LDL) cholesterol (-0.36 mmol[l.sup.- 1], P = 0.008) and visceral fat area (-5.5 [cm.sup.2], P = 0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change. CONCLUSION: Habitual and structured PAs with the acceleration levels of 0.3-0.7g and daily steps over 6520, equivalent to walking at 2-3 km [h.sup.-1] for 90 min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. International Journal of Obesity (2014) 38, 1089-1096; doi:10.1038/ijo.2013.224 Keywords: overweight; insulin resistance; visceral fat; lipids; accelerometer To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D). A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3kgm(-2) were randomly assigned to intervention and control groups. INTERVENTION consisted of a supervised walking (60min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time. Over 80% of the daily steps clustered at an acceleration level of 0.3-0.7g (2-3kmh(-1) of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4mUl(-1), P=0.035 and -26.6, P=0.003, respectively), homeostasis model assessment-estimated insulin resistance (-1.0, P=0.036), total cholesterol (-0.55mmoll(-1), P=0.041), low-density lipoprotein (LDL) cholesterol (-0.36mmoll(-1), P=0.008) and visceral fat area (-5.5cm(2), P=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change. Habitual and structured PAs with the acceleration levels of 0.3-0.7g and daily steps over 6520, equivalent to walking at 2-3kmh(-1) for 90min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. Objective: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D).Intervention:A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8 plus or minus 10.4 years and body mass index 31.7 plus or minus 5.3 kg m super(-2) were randomly assigned to intervention and control groups. Intervention consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time. Results: Over 80% of the daily steps clustered at an acceleration level of 0.3-0.7 g (2-3 km h super(-1) of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4 mU l super(-1) , P=0.035 and -26.6, P=0.003, respectively), homeostasis model assessment-estimated insulin resistance (-1.0, P=0.036), total cholesterol (-0.55 mmol l super(-1), P=0.041), low-density lipoprotein (LDL) cholesterol (-0.36 mmol l super(-1), P=0.008) and visceral fat area (-5.5 cm super(2), P=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change. Conclusion: Habitual and structured PAs with the acceleration levels of 0.3-0.7 g and daily steps over 6520, equivalent to walking at 2-3 km h super(-1) for 90 min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D). A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3 kg m(-2) were randomly assigned to intervention and control groups. INTERVENTION consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time. Over 80% of the daily steps clustered at an acceleration level of 0.3-0.7 g (2-3 km h(-1) of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4 mU l(-1), P=0.035 and -26.6, P=0.003, respectively), homeostasis model assessment-estimated insulin resistance (-1.0, P=0.036), total cholesterol (-0.55 mmol l(-1), P=0.041), low-density lipoprotein (LDL) cholesterol (-0.36 mmol l(-1), P=0.008) and visceral fat area (-5.5 cm(2), P=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change. Habitual and structured PAs with the acceleration levels of 0.3-0.7 g and daily steps over 6520, equivalent to walking at 2-3 km h(-1) for 90 min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D).OBJECTIVETo examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D).A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3 kg m(-2) were randomly assigned to intervention and control groups. INTERVENTION consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time.INTERVENTIONA total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3 kg m(-2) were randomly assigned to intervention and control groups. INTERVENTION consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time.Over 80% of the daily steps clustered at an acceleration level of 0.3-0.7 g (2-3 km h(-1) of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4 mU l(-1), P=0.035 and -26.6, P=0.003, respectively), homeostasis model assessment-estimated insulin resistance (-1.0, P=0.036), total cholesterol (-0.55 mmol l(-1), P=0.041), low-density lipoprotein (LDL) cholesterol (-0.36 mmol l(-1), P=0.008) and visceral fat area (-5.5 cm(2), P=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change.RESULTSOver 80% of the daily steps clustered at an acceleration level of 0.3-0.7 g (2-3 km h(-1) of walking) and were 5870 in the intervention and 4434 in the control group (P<0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (-3.4 mU l(-1), P=0.035 and -26.6, P=0.003, respectively), homeostasis model assessment-estimated insulin resistance (-1.0, P=0.036), total cholesterol (-0.55 mmol l(-1), P=0.041), low-density lipoprotein (LDL) cholesterol (-0.36 mmol l(-1), P=0.008) and visceral fat area (-5.5 cm(2), P=0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780-2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change.Habitual and structured PAs with the acceleration levels of 0.3-0.7 g and daily steps over 6520, equivalent to walking at 2-3 km h(-1) for 90 min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D.CONCLUSIONHabitual and structured PAs with the acceleration levels of 0.3-0.7 g and daily steps over 6520, equivalent to walking at 2-3 km h(-1) for 90 min daily, standing for the relative PA intensity of 30-35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. International Journal of Obesity (2014) 38, 1089-1096; doi:10.1038/ijo.2013.224 Objective: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2 diabetes (T2D). Intervention: A total of 113 subjects of both genders having abnormal glucose levels in the oral glucose tolerance test were contacted. A total of 78 subjects with age 58.8±10.4 years and body mass index 31.7±5.3 kg m −2 were randomly assigned to intervention and control groups. Intervention consisted of a supervised walking (60 min three times weekly) for 3 months. All the subjects received standard care for PA and weight reduction and wore an accelerometer during the whole wakeful time. Results: Over 80% of the daily steps clustered at an acceleration level of 0.3–0.7 g (2–3 km h −1 of walking) and were 5870 in the intervention and 4434 in the control group ( P <0.029). Between 0 and 3 months no significant changes were observed in fasting and 2-h glucose, body weight or maximal oxygen uptake. In contrast, changes in fasting and 2-h insulin (−3.4 mU l −1 , P =0.035 and −26.6, P =0.003, respectively), homeostasis model assessment-estimated insulin resistance (−1.0, P =0.036), total cholesterol (−0.55 mmol l −1 , P =0.041), low-density lipoprotein (LDL) cholesterol (−0.36 mmol l −1 , P =0.008) and visceral fat area (−5.5 cm 2 , P =0.030) were significantly greater in the intervention than in control subjects. The overall effects of PA were analyzed by quartiles of daily steps of all subjects. There were significant reductions in total and LDL cholesterol and visceral fat area between the highest (daily steps over 6520) and the lowest quartile (1780–2810 daily steps). The changes associated with PA remained significant after adjustments of baseline, sex, age and body weight change. Conclusion: Habitual and structured PAs with the acceleration levels of 0.3–0.7 g and daily steps over 6520, equivalent to walking at 2–3 km h −1 for 90 min daily, standing for the relative PA intensity of 30–35% of the maximal oxygen uptake, are clinically beneficial for overweight/obese and physically inactive individuals with a high risk for T2D. |
| Audience | Academic |
| Author | Keinänen-Kiukaanniemi, S Jokelainen, J Ahola, R Jämsä, T Leppäluoto, J Herzig, K-H |
| Author_xml | – sequence: 1 givenname: K-H surname: Herzig fullname: Herzig, K-H email: Karl-Heinz.Herzig@oulu.fi organization: Department of Physiology and Biocenter of Oulu, Institute of Biomedicine, Oulu University, Medical Research Center Oulu and Oulu University Hospital – sequence: 2 givenname: R surname: Ahola fullname: Ahola, R organization: Department of Medical Technology, University of Oulu – sequence: 3 givenname: J surname: Leppäluoto fullname: Leppäluoto, J organization: Department of Physiology and Biocenter of Oulu, Institute of Biomedicine, Oulu University – sequence: 4 givenname: J surname: Jokelainen fullname: Jokelainen, J organization: Institute of Health Sciences, University of Oulu – sequence: 5 givenname: T surname: Jämsä fullname: Jämsä, T organization: Department of Medical Technology, University of Oulu – sequence: 6 givenname: S surname: Keinänen-Kiukaanniemi fullname: Keinänen-Kiukaanniemi, S organization: Institute of Health Sciences, University of Oulu, Oulu University Hospital, Unit of General Practice, and Health Center of Oulu |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28665541$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24285336$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFk01v1DAQhiNURD_gxhlZQiAOzWIndpLlgFQt5UOqBELlbDnOZOMlsRfbWbF_i1_IpNvCtipCOUTK-8zr8eSd4-TAOgtJ8pTRGaN59dqs3CyjLJ9lGX-QHDFeFqng8_IgOaI5LVMqCnGYHIewopQKQbNHyWHGs0rkeXGU_Lowyy6SdbcNRqueKB3NxsQtaSCCH4yFhtRbosjgonGWBLDBeVS1BxUgEGPD2BtLPAQTorIaTokZ1t5tUOzN2jSkcwM41BAgyjaINqNGdWOCBo-HtiqiD-mwldSb8J2EsV6BjuEN-eLhnVH1-U8S4thsydfF5ePkYav6AE-u3yfJt_fnl4uP6cXnD58WZxepLnkZ03oOGgDypmoLCqwSRc4qUFVTtJzOG03rnFNNC8VqTquyaVuuclo1ZcUFb5E-Sd7ufNdjPUCjwUZsVq69GZTfSqeMvK1Y08ml20jOMlHyORq8ujbw7scIIcphunHfKwtuDJIVWVbQUlTZ_1EhWMFYWTBEn99BV270FidxRbG8yvM9aql6kMa2DlvUk6k8yyuGv59eUbN7KHwaGIzGnLUGv98qeLlX0IHqYxdcP07ZCLfBZ_vD-zO1m-Qh8OIaUAGD13qMjgl_uaoohOCTUbbjtHcheGilNlFN52GrppeMymkNJK6BnNZA4hpg0emdohvff-DpDg-I2SX4vZHex_8GqHQY8A |
| CODEN | IJOBDP |
| CitedBy_id | crossref_primary_10_1177_0890117118816278 crossref_primary_10_1038_ijo_2017_49 crossref_primary_10_1136_bmjsem_2016_000143 crossref_primary_10_1007_s00421_023_05296_z crossref_primary_10_1016_j_mayocp_2015_07_022 crossref_primary_10_1177_20552076241260921 crossref_primary_10_3390_brainsci13060950 crossref_primary_10_3390_ijerph19095433 crossref_primary_10_1007_s11920_016_0721_2 crossref_primary_10_1111_sms_13567 crossref_primary_10_3389_fendo_2024_1308959 crossref_primary_10_1249_MSS_0000000000001932 crossref_primary_10_3389_fphys_2023_1151389 crossref_primary_10_1123_japa_2020_0317 crossref_primary_10_5694_mja2_52483 crossref_primary_10_1017_S2040174420000343 crossref_primary_10_1590_1517_869220172302158989 crossref_primary_10_1371_journal_pone_0295092 crossref_primary_10_1186_s12966_020_00978_9 crossref_primary_10_3389_fendo_2023_1233312 crossref_primary_10_1001_jamanetworkopen_2024_52185 crossref_primary_10_1371_journal_pone_0184472 crossref_primary_10_3389_fendo_2019_00116 crossref_primary_10_3389_fphys_2022_809669 crossref_primary_10_1111_obr_13528 crossref_primary_10_1210_clinem_dgab810 crossref_primary_10_1002_14651858_CD008823_pub2 crossref_primary_10_1016_j_ypmed_2017_07_033 crossref_primary_10_3390_nu14235045 crossref_primary_10_1016_j_jshs_2023_03_001 crossref_primary_10_1371_journal_pone_0143925 crossref_primary_10_5888_pcd13_160159 crossref_primary_10_3390_jcm11123267 crossref_primary_10_1080_08964289_2018_1538098 crossref_primary_10_1007_s11892_016_0748_0 crossref_primary_10_3390_cells9051189 crossref_primary_10_3390_ijerph15051042 crossref_primary_10_1186_s12889_020_09929_2 crossref_primary_10_1371_journal_pone_0219798 crossref_primary_10_1136_bjsports_2020_103594 crossref_primary_10_1371_journal_pone_0268289 crossref_primary_10_3389_fphys_2019_00456 crossref_primary_10_1001_jamainternmed_2019_0899 crossref_primary_10_1007_s40279_017_0724_0 crossref_primary_10_1161_CIR_0000000000000973 crossref_primary_10_1186_s12905_018_0598_9 crossref_primary_10_1007_s40279_017_0825_9 crossref_primary_10_1136_bjsports_2017_098558 crossref_primary_10_1007_s12640_015_9528_x crossref_primary_10_1249_JSR_0000000000000868 crossref_primary_10_3390_ijerph18158042 crossref_primary_10_3389_fendo_2021_693683 crossref_primary_10_1159_000375103 crossref_primary_10_1016_j_cc_2016_01_004 crossref_primary_10_1038_s41598_021_97299_z crossref_primary_10_1038_s41598_017_09753_6 crossref_primary_10_1038_s41366_021_00767_9 crossref_primary_10_1007_s40279_021_01536_4 |
| Cites_doi | 10.1186/1479-5868-7-60 10.2337/dc09-0130 10.1007/s00198-005-0005-x 10.1016/0140-6736(91)90664-B 10.1136/bmj.322.7288.716 10.1210/jc.2008-0222 10.2337/diacare.28.6.1503 10.1001/jama.1995.03520290054029 10.1371/journal.pone.0018942 10.1249/MSS.0b013e318213fefb 10.1097/00001648-199011000-00011 10.1056/NEJM199107183250302 10.1249/mss.0b013e31815a51b3 10.2337/diacare.20.4.537 10.1152/japplphysiol.01336.2005 10.1016/1047-2797(94)00100-8 10.1016/j.clinbiomech.2005.10.003 10.1016/j.amepre.2010.12.016 10.1016/S0140-6736(12)60283-9 10.2337/dc06-9910 10.1056/NEJMoa012512 10.1038/sj.ijo.0802485 10.1001/archinternmed.2011.275 10.1002/hep.23129 10.2337/diacare.26.3.725 10.2337/dc09-1099 10.1056/NEJM200105033441801 10.1038/ijo.2008.280 10.1016/0378-5122(94)00878-B 10.1249/mss.0b013e318031c039 10.1007/s00125-013-2845-9 10.2337/dc11-1272 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2014 2015 INIST-CNRS COPYRIGHT 2014 Nature Publishing Group Copyright Nature Publishing Group Aug 2014 Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited |
| Copyright_xml | – notice: The Author(s) 2014 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2014 Nature Publishing Group – notice: Copyright Nature Publishing Group Aug 2014 – notice: Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited |
| DBID | C6C AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
| DOI | 10.1038/ijo.2013.224 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database (subscription) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Agricultural & Environmental Science Collection (subscription) ProQuest Central Essentials Biological Science Collection (subscription) ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database ProQuest Psychology Database Biological science database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database Physical Education Index MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
| DocumentTitleAlternate | Light physical activity in high-risk subjects |
| EISSN | 1476-5497 |
| EndPage | 1096 |
| ExternalDocumentID | PMC4125749 3392576121 A381285031 24285336 28665541 10_1038_ijo_2013_224 |
| Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Finland United States United States--US |
| GeographicLocations_xml | – name: Finland – name: United States – name: United States--US |
| GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ C6C DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION IQODW --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABIVO ABJNI ABLJU ABRTQ ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADHUB ADXHL AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV AMYLF APEBS ATHPR AXYYD AYFIA BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c747t-b9eceee3d8f60e1856318ea8d6f409dc0b340c06a1b4087dff4a308d78454f563 |
| IEDL.DBID | 7X7 |
| ISSN | 0307-0565 1476-5497 |
| IngestDate | Thu Aug 21 14:11:36 EDT 2025 Fri Jul 11 06:33:51 EDT 2025 Tue Aug 05 10:27:54 EDT 2025 Wed Jul 16 16:01:24 EDT 2025 Tue Jun 17 21:38:14 EDT 2025 Tue Jun 10 20:49:32 EDT 2025 Thu May 22 21:19:16 EDT 2025 Mon Jul 21 05:55:46 EDT 2025 Wed Apr 02 07:35:47 EDT 2025 Tue Jul 01 03:01:52 EDT 2025 Thu Apr 24 23:09:44 EDT 2025 Fri Feb 21 02:39:36 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | lipids overweight insulin resistance visceral fat accelerometer Endocrinopathy Physical exercise Visceral fat Human Motion High risk Pancreatic hormone Body weight Nutrition disorder Measurement sensor Homeostasis Lipids Corporal biometry Insulin Overweight Target tissue resistance Improvement Randomization Light Clinical trial Insulin resistance Nutritional status |
| Language | English |
| License | http://www.springer.com/tdm CC BY 4.0 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c747t-b9eceee3d8f60e1856318ea8d6f409dc0b340c06a1b4087dff4a308d78454f563 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.nature.com/articles/ijo.2013.224 |
| PMID | 24285336 |
| PQID | 1551138331 |
| PQPubID | 38864 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4125749 proquest_miscellaneous_1622607582 proquest_miscellaneous_1551611761 proquest_journals_1551138331 gale_infotracmisc_A381285031 gale_infotracacademiconefile_A381285031 gale_healthsolutions_A381285031 pubmed_primary_24285336 pascalfrancis_primary_28665541 crossref_citationtrail_10_1038_ijo_2013_224 crossref_primary_10_1038_ijo_2013_224 springer_journals_10_1038_ijo_2013_224 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-08-01 |
| PublicationDateYYYYMMDD | 2014-08-01 |
| PublicationDate_xml | – month: 08 year: 2014 text: 2014-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
| PublicationTitle | International Journal of Obesity |
| PublicationTitleAbbrev | Int J Obes |
| PublicationTitleAlternate | Int J Obes (Lond) |
| PublicationYear | 2014 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | (CR2) 2012; 61 Yates, Davies, Gorely, Bull, Khunti (CR17) 2009; 32 Manson, Rimm (CR4) 1991; 338 Jämsä, Vainionpää, Korpelainen, Vihriälä, Leppäluoto (CR26) 2006; 21 Johnson, Tudor-Locke, McCarger, Bell (CR13) 2005; 28 Vainionpää, Korpelainen, Vihriälä, Rinta-Paavola, Leppäluoto, Jämsä (CR28) 2006; 17 Saito, Watanabe, Hishida, Izumi, Omura, Takagi (CR30) 2011; 171 Sigal, Kenny, Wasserman, Castandea-Sceppa, White (CR10) 2006; 29 O'Leary, Marchetti, Krishnan, Bradley, Stetzer, Kirwan (CR36) 2006; 100 Henson, Yates, Biddle, Edwardson, Khunti, Wilmont (CR37) 2013; 56 Knowler, Barrett-Connor, Fowler, Hamman, Lachlin, Walker (CR7) 2002; 346 Ainsworth, Haskell, Whitt, Irwin, Swartz, Strath (CR11) 2000; 32 Jakicic, Jaramillo, Balasupramanyam, Bancroft, Curtis, Mathews (CR34) 2009; 33 Pan, Li, Hu, Wang, An, Hu (CR5) 1997; 20 Després, Lemieux, Prud'homme (CR33) 2001; 322 Jaglal, Kreiger, Darlington (CR22) 1995; 5 Lange Andersen, Basironi, Rutenfranz, Seliner (CR25) 1978 Tucker, Welk, Beyler (CR15) 2011; 40 Pate, Pratt, Blair, Haskel, Macear, Bouchard (CR16) 2005; 273 Tudor-Locke, Bell, Myers, Harris, Ecclestone, Lauzon (CR18) 2004; 28 Pomeroy, Brage, Curtis, Swan, Knowler, Franks (CR12) 2011; 6 Helmrich, Ragland, Leung, Paffenbarger (CR3) 1991; 325 Tuomilehto, Lindström, Eriksson, Valle, Hämäläinen, Ilanne-Parikka (CR6) 2001; 344 Garber, Blissmer, Deschenes, Franklin, Lamonte, Lee (CR9) 2011; 43 Vihriälä, Oksa, Karkulehto, Korpelainen, Myllylä, Jämsä (CR27) 2004; 12 Vainionpää, Korpelainen, Kaikkonen, Knip, Leppäluoto, Jämsä (CR29) 2007; 39 Rosenzweig, Ferannini, Grudy, Haffner, Heine, Horton (CR8) 2008; 93 Dwyer, Ponsonby, Ukoumunne, Pezic, Venn, Dunstan (CR31) 2010; 341 Mello, Lindström, Eriksson, Ilanne-Parikka, Keinänen-Kiukaanniemi, Sundvall (CR32) 2012; 35 Tudor-Locke, Brashear, Johnson, Katzmarzyk (CR19) 2010; 7 Tuppurainen, Kröger, Saarikoski, Honkanen, Alhava (CR24) 1995; 21 Troiano, Berrigan, Dodd, Mâsse, Tilert, McDowell (CR14) 2008; 40 Tabák, Herder, Rathmann, Brunner, Kivimäki (CR1) 2012; 379 Nagai, Komiya, Mori, Ohta, Kasahar, Ikeda (CR21) 2010; 33 Lindström, Tuomilehto (CR20) 2003; 26 Slattery, Abd-Elghany, Kerber, Schumacher (CR23) 1990; 1 Johnson, Sachinwalla, Walton, Smith, Armstrong, Thompson (CR35) 2009; 50 A Vainionpää (BFijo2013224_CR28) 2006; 17 C Tudor-Locke (BFijo2013224_CR19) 2010; 7 NA Johnson (BFijo2013224_CR35) 2009; 50 K Lange Andersen (BFijo2013224_CR25) 1978 X-R Pan (BFijo2013224_CR5) 1997; 20 J Tuomilehto (BFijo2013224_CR6) 2001; 344 J Lindström (BFijo2013224_CR20) 2003; 26 E Vihriälä (BFijo2013224_CR27) 2004; 12 A Vainionpää (BFijo2013224_CR29) 2007; 39 JL Rosenzweig (BFijo2013224_CR8) 2008; 93 T Saito (BFijo2013224_CR30) 2011; 171 JE Manson (BFijo2013224_CR4) 1991; 338 ML Slattery (BFijo2013224_CR23) 1990; 1 SP Helmrich (BFijo2013224_CR3) 1991; 325 WC Knowler (BFijo2013224_CR7) 2002; 346 LM Jakicic (BFijo2013224_CR34) 2009; 33 J Pomeroy (BFijo2013224_CR12) 2011; 6 M Tuppurainen (BFijo2013224_CR24) 1995; 21 AG Tabák (BFijo2013224_CR1) 2012; 379 T Yates (BFijo2013224_CR17) 2009; 32 J-P Després (BFijo2013224_CR33) 2001; 322 RP Troiano (BFijo2013224_CR14) 2008; 40 CE Garber (BFijo2013224_CR9) 2011; 43 M Nagai (BFijo2013224_CR21) 2010; 33 Centers for Disease Control and Prevention (CDC) (BFijo2013224_CR2) 2012; 61 VB O'Leary (BFijo2013224_CR36) 2006; 100 SB Jaglal (BFijo2013224_CR22) 1995; 5 S Johnson (BFijo2013224_CR13) 2005; 28 C Tudor-Locke (BFijo2013224_CR18) 2004; 28 T Jämsä (BFijo2013224_CR26) 2006; 21 RJ Sigal (BFijo2013224_CR10) 2006; 29 J Henson (BFijo2013224_CR37) 2013; 56 BE Ainsworth (BFijo2013224_CR11) 2000; 32 JM Tucker (BFijo2013224_CR15) 2011; 40 VDF Mello (BFijo2013224_CR32) 2012; 35 RR Pate (BFijo2013224_CR16) 2005; 273 T Dwyer (BFijo2013224_CR31) 2010; 341 17468572 - Med Sci Sports Exerc. 2007 May;39(5):756-63 22210578 - Diabetes Care. 2012 Feb;35(2):211-7 21556140 - PLoS One. 2011;6(4):e18942 22683128 - Lancet. 2012 Jun 16;379(9833):2279-90 18091006 - Med Sci Sports Exerc. 2008 Jan;40(1):181-8 23151951 - MMWR Morb Mortal Wkly Rep. 2012 Nov 16;61(45):918-21 8520716 - Ann Epidemiol. 1995 Jul;5(4):321-4 21406280 - Am J Prev Med. 2011 Apr;40(4):454-61 15920080 - Diabetes Care. 2005 Jun;28(6):1503-4 11264213 - BMJ. 2001 Mar 24;322(7288):716-20 2090287 - Epidemiology. 1990 Nov;1(6):481-5 19637289 - Hepatology. 2009 Oct;50(4):1105-12 16373444 - J Appl Physiol (1985). 2006 May;100(5):1584-9 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 12610029 - Diabetes Care. 2003 Mar;26(3):725-31 10993420 - Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504 19602539 - Diabetes Care. 2009 Aug;32(8):1404-10 9096977 - Diabetes Care. 1997 Apr;20(4):537-44 16732040 - Diabetes Care. 2006 Jun;29(6):1433-8 21694556 - Med Sci Sports Exerc. 2011 Jul;43(7):1334-59 20682057 - Int J Behav Nutr Phys Act. 2010 Aug 03;7:60 1681160 - Lancet. 1991 Sep 28;338(8770):774-8 2052059 - N Engl J Med. 1991 Jul 18;325(3):147-52 7823386 - JAMA. 1995 Feb 1;273(5):402-7 19153582 - Int J Obes (Lond). 2009 Mar;33(3):305-16 21233153 - BMJ. 2011;342:c7249 16404492 - Osteoporos Int. 2006;17(3):455-63 18664543 - J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89 23456209 - Diabetologia. 2013 May;56(5):1012-20 20150289 - Diabetes Care. 2010 May;33(5):1077-9 14569279 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):113-9 16298464 - Clin Biomech (Bristol, Avon). 2006 Jan;21(1):1-7 7752951 - Maturitas. 1995 Feb;21(2):137-45 21824948 - Arch Intern Med. 2011 Aug 8;171(15):1352-60 11333990 - N Engl J Med. 2001 May 3;344(18):1343-50 |
| References_xml | – volume: 341 start-page: c7249 year: 2010 ident: CR31 article-title: Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study publication-title: BMJ – volume: 7 start-page: 60 year: 2010 ident: CR19 article-title: Accelerometer profiles of physical activity and inactivity in normal weight, overweight, and obese U.S. men and women publication-title: Int J Behav Nutr Phys Sci doi: 10.1186/1479-5868-7-60 – volume: 32 start-page: 1404 year: 2009 end-page: 1410 ident: CR17 article-title: Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance publication-title: Diabetes Care doi: 10.2337/dc09-0130 – volume: 17 start-page: 455 year: 2006 end-page: 463 ident: CR28 article-title: Intensity of exercise is associated with bone density change in premenopausal women publication-title: Osteoporos Int doi: 10.1007/s00198-005-0005-x – volume: 32 start-page: S498 issue: 9 Suppl year: 2000 end-page: S504 ident: CR11 article-title: Compendium of physical activities: an update of activity codes and MET intensities publication-title: Med Sci Sports Med – volume: 12 start-page: 122 year: 2004 end-page: 124 ident: CR27 article-title: Reliability of an accelerometer in the assessment of body movements publication-title: Technolog Health Care – volume: 338 start-page: 774 year: 1991 end-page: 778 ident: CR4 article-title: Physical activity and incidence of non-insulin dependent diabetes mellitus in women publication-title: Lancet doi: 10.1016/0140-6736(91)90664-B – volume: 322 start-page: 716 year: 2001 end-page: 720 ident: CR33 article-title: Treatment of obesity: need to focus on high risk abdominally obese patients publication-title: BMJ doi: 10.1136/bmj.322.7288.716 – volume: 93 start-page: 3671 year: 2008 end-page: 3689 ident: CR8 article-title: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0222 – volume: 28 start-page: 1503 year: 2005 end-page: 1504 ident: CR13 article-title: Measuring habitual walking speed of people with type 2 diabetes publication-title: Diabetes Care doi: 10.2337/diacare.28.6.1503 – volume: 273 start-page: 402 year: 2005 end-page: 407 ident: CR16 article-title: Physical activity and public health. A recommendation from the Centers for Disease Control and the American College of Sports Medicine publication-title: JAMA doi: 10.1001/jama.1995.03520290054029 – volume: 6 start-page: e18942 year: 2011 ident: CR12 article-title: Between-monitor differences in step counts are related to body size: implications for objective physical activity measurement publication-title: PLoS One doi: 10.1371/journal.pone.0018942 – volume: 43 start-page: 1334 year: 2011 end-page: 1359 ident: CR9 article-title: Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescripting exercise publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e318213fefb – volume: 1 start-page: 481 year: 1990 end-page: 485 ident: CR23 article-title: Physical activity and colon cancer: a comparison of various indicators of physical activity to evaluate the association publication-title: Epidemiology doi: 10.1097/00001648-199011000-00011 – volume: 325 start-page: 147 year: 1991 end-page: 152 ident: CR3 article-title: Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus publication-title: N Engl J Med doi: 10.1056/NEJM199107183250302 – volume: 40 start-page: 181 year: 2008 end-page: 188 ident: CR14 article-title: physical activity in the United States measured by accelerometer publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e31815a51b3 – volume: 20 start-page: 537 year: 1997 end-page: 544 ident: CR5 article-title: Effect of diet and exercise in preventing NIMDD in people with impaired glucose tolerance. The Da Quing IGT and diabetes study publication-title: Diabetes Care doi: 10.2337/diacare.20.4.537 – volume: 100 start-page: 1584 year: 2006 end-page: 1589 ident: CR36 article-title: Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat publication-title: J Appl Physiol doi: 10.1152/japplphysiol.01336.2005 – volume: 5 start-page: 321 year: 1995 end-page: 324 ident: CR22 article-title: Lifetime occupational physical activity and risk of hip fracture in women publication-title: Ann Epidemiol doi: 10.1016/1047-2797(94)00100-8 – volume: 21 start-page: 1 year: 2006 end-page: 7 ident: CR26 article-title: Effect of daily physical activity on proximal femur publication-title: Clin Biomech doi: 10.1016/j.clinbiomech.2005.10.003 – volume: 40 start-page: 454 year: 2011 end-page: 461 ident: CR15 article-title: Physical activity in US adults: compliance with the physical activity guidelines for Americans publication-title: Am J Prev Med doi: 10.1016/j.amepre.2010.12.016 – volume: 61 start-page: 918 year: 2012 end-page: 921 ident: CR2 article-title: Increasing prevalence of diagnosed diabetes—United States and Puerto Rico, 1995-2010 publication-title: MMWR Morb Mortal Wkly Rep – volume: 379 start-page: 2279 year: 2012 end-page: 2290 ident: CR1 article-title: Prediabetes: a high-risk state for diabetes development publication-title: Lancet doi: 10.1016/S0140-6736(12)60283-9 – volume: 29 start-page: 1433 year: 2006 end-page: 1438 ident: CR10 article-title: Physical activity/exercise and type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc06-9910 – volume: 346 start-page: 393 year: 2002 end-page: 403 ident: CR7 article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin publication-title: N Engl J Med doi: 10.1056/NEJMoa012512 – volume: 28 start-page: 113 year: 2004 end-page: 119 ident: CR18 article-title: Controlled outcome evaluation of the first step program: a daily physical activity intervention for individuals with type II diabetes publication-title: Int J Obes doi: 10.1038/sj.ijo.0802485 – volume: 171 start-page: 1352 year: 2011 end-page: 1360 ident: CR30 article-title: Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose publication-title: Ann Intern Med doi: 10.1001/archinternmed.2011.275 – volume: 50 start-page: 1105 year: 2009 end-page: 1112 ident: CR35 article-title: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss publication-title: Hepatology doi: 10.1002/hep.23129 – volume: 26 start-page: 725 year: 2003 end-page: 731 ident: CR20 article-title: The diabetes risk score: a practical tool to predict type 2 diabetes risk publication-title: Diabetes Care doi: 10.2337/diacare.26.3.725 – volume: 33 start-page: 1077 year: 2010 end-page: 1079 ident: CR21 article-title: Estimating visceral fat area by multifrequency bioelectrical impedance publication-title: Diabetes Care doi: 10.2337/dc09-1099 – volume: 344 start-page: 1343 year: 2001 end-page: 1350 ident: CR6 article-title: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance publication-title: N Engl J Med doi: 10.1056/NEJM200105033441801 – volume: 33 start-page: 305 year: 2009 end-page: 316 ident: CR34 article-title: Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study publication-title: Int J Obesity doi: 10.1038/ijo.2008.280 – volume: 21 start-page: 137 year: 1995 end-page: 145 ident: CR24 article-title: The effects of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women publication-title: Maturitas doi: 10.1016/0378-5122(94)00878-B – volume: 39 start-page: 756 year: 2007 end-page: 763 ident: CR29 article-title: Effect of impact exercise on physical performance and cardiovascular risk factors publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e318031c039 – volume: 56 start-page: 1012 year: 2013 end-page: 1020 ident: CR37 article-title: Associations of objectively measured sedentary behavior and physical activity with markers of cardiometabolic health publication-title: Diabetologia doi: 10.1007/s00125-013-2845-9 – year: 1978 ident: CR25 publication-title: Habitual Physical Activity and Health – volume: 35 start-page: 211 year: 2012 end-page: 217 ident: CR32 article-title: Insulin secretion and its determinant in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals publication-title: Diabetes Care doi: 10.2337/dc11-1272 – volume: 32 start-page: 1404 year: 2009 ident: BFijo2013224_CR17 publication-title: Diabetes Care doi: 10.2337/dc09-0130 – volume: 61 start-page: 918 year: 2012 ident: BFijo2013224_CR2 publication-title: MMWR Morb Mortal Wkly Rep – volume: 273 start-page: 402 year: 2005 ident: BFijo2013224_CR16 publication-title: JAMA doi: 10.1001/jama.1995.03520290054029 – volume: 346 start-page: 393 year: 2002 ident: BFijo2013224_CR7 publication-title: N Engl J Med doi: 10.1056/NEJMoa012512 – volume: 29 start-page: 1433 year: 2006 ident: BFijo2013224_CR10 publication-title: Diabetes Care doi: 10.2337/dc06-9910 – volume: 28 start-page: 1503 year: 2005 ident: BFijo2013224_CR13 publication-title: Diabetes Care doi: 10.2337/diacare.28.6.1503 – volume: 5 start-page: 321 year: 1995 ident: BFijo2013224_CR22 publication-title: Ann Epidemiol doi: 10.1016/1047-2797(94)00100-8 – volume: 39 start-page: 756 year: 2007 ident: BFijo2013224_CR29 publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e318031c039 – volume: 322 start-page: 716 year: 2001 ident: BFijo2013224_CR33 publication-title: BMJ doi: 10.1136/bmj.322.7288.716 – volume-title: Habitual Physical Activity and Health year: 1978 ident: BFijo2013224_CR25 – volume: 344 start-page: 1343 year: 2001 ident: BFijo2013224_CR6 publication-title: N Engl J Med doi: 10.1056/NEJM200105033441801 – volume: 50 start-page: 1105 year: 2009 ident: BFijo2013224_CR35 publication-title: Hepatology doi: 10.1002/hep.23129 – volume: 40 start-page: 181 year: 2008 ident: BFijo2013224_CR14 publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e31815a51b3 – volume: 33 start-page: 1077 year: 2010 ident: BFijo2013224_CR21 publication-title: Diabetes Care doi: 10.2337/dc09-1099 – volume: 325 start-page: 147 year: 1991 ident: BFijo2013224_CR3 publication-title: N Engl J Med doi: 10.1056/NEJM199107183250302 – volume: 28 start-page: 113 year: 2004 ident: BFijo2013224_CR18 publication-title: Int J Obes doi: 10.1038/sj.ijo.0802485 – volume: 56 start-page: 1012 year: 2013 ident: BFijo2013224_CR37 publication-title: Diabetologia doi: 10.1007/s00125-013-2845-9 – volume: 21 start-page: 1 year: 2006 ident: BFijo2013224_CR26 publication-title: Clin Biomech doi: 10.1016/j.clinbiomech.2005.10.003 – volume: 12 start-page: 122 year: 2004 ident: BFijo2013224_CR27 publication-title: Technolog Health Care – volume: 35 start-page: 211 year: 2012 ident: BFijo2013224_CR32 publication-title: Diabetes Care doi: 10.2337/dc11-1272 – volume: 7 start-page: 60 year: 2010 ident: BFijo2013224_CR19 publication-title: Int J Behav Nutr Phys Sci doi: 10.1186/1479-5868-7-60 – volume: 40 start-page: 454 year: 2011 ident: BFijo2013224_CR15 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2010.12.016 – volume: 1 start-page: 481 year: 1990 ident: BFijo2013224_CR23 publication-title: Epidemiology doi: 10.1097/00001648-199011000-00011 – volume: 338 start-page: 774 year: 1991 ident: BFijo2013224_CR4 publication-title: Lancet doi: 10.1016/0140-6736(91)90664-B – volume: 20 start-page: 537 year: 1997 ident: BFijo2013224_CR5 publication-title: Diabetes Care doi: 10.2337/diacare.20.4.537 – volume: 171 start-page: 1352 year: 2011 ident: BFijo2013224_CR30 publication-title: Ann Intern Med doi: 10.1001/archinternmed.2011.275 – volume: 43 start-page: 1334 year: 2011 ident: BFijo2013224_CR9 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e318213fefb – volume: 100 start-page: 1584 year: 2006 ident: BFijo2013224_CR36 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.01336.2005 – volume: 32 start-page: S498 issue: 9 Suppl year: 2000 ident: BFijo2013224_CR11 publication-title: Med Sci Sports Med – volume: 33 start-page: 305 year: 2009 ident: BFijo2013224_CR34 publication-title: Int J Obesity doi: 10.1038/ijo.2008.280 – volume: 341 start-page: c7249 year: 2010 ident: BFijo2013224_CR31 publication-title: BMJ – volume: 21 start-page: 137 year: 1995 ident: BFijo2013224_CR24 publication-title: Maturitas doi: 10.1016/0378-5122(94)00878-B – volume: 17 start-page: 455 year: 2006 ident: BFijo2013224_CR28 publication-title: Osteoporos Int doi: 10.1007/s00198-005-0005-x – volume: 6 start-page: e18942 year: 2011 ident: BFijo2013224_CR12 publication-title: PLoS One doi: 10.1371/journal.pone.0018942 – volume: 26 start-page: 725 year: 2003 ident: BFijo2013224_CR20 publication-title: Diabetes Care doi: 10.2337/diacare.26.3.725 – volume: 379 start-page: 2279 year: 2012 ident: BFijo2013224_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(12)60283-9 – volume: 93 start-page: 3671 year: 2008 ident: BFijo2013224_CR8 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0222 – reference: 14569279 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):113-9 – reference: 11333990 - N Engl J Med. 2001 May 3;344(18):1343-50 – reference: 16298464 - Clin Biomech (Bristol, Avon). 2006 Jan;21(1):1-7 – reference: 16373444 - J Appl Physiol (1985). 2006 May;100(5):1584-9 – reference: 2090287 - Epidemiology. 1990 Nov;1(6):481-5 – reference: 7823386 - JAMA. 1995 Feb 1;273(5):402-7 – reference: 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 – reference: 19153582 - Int J Obes (Lond). 2009 Mar;33(3):305-16 – reference: 12610029 - Diabetes Care. 2003 Mar;26(3):725-31 – reference: 11264213 - BMJ. 2001 Mar 24;322(7288):716-20 – reference: 16732040 - Diabetes Care. 2006 Jun;29(6):1433-8 – reference: 18091006 - Med Sci Sports Exerc. 2008 Jan;40(1):181-8 – reference: 9096977 - Diabetes Care. 1997 Apr;20(4):537-44 – reference: 22683128 - Lancet. 2012 Jun 16;379(9833):2279-90 – reference: 18664543 - J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89 – reference: 15920080 - Diabetes Care. 2005 Jun;28(6):1503-4 – reference: 21694556 - Med Sci Sports Exerc. 2011 Jul;43(7):1334-59 – reference: 20150289 - Diabetes Care. 2010 May;33(5):1077-9 – reference: 21406280 - Am J Prev Med. 2011 Apr;40(4):454-61 – reference: 21824948 - Arch Intern Med. 2011 Aug 8;171(15):1352-60 – reference: 17468572 - Med Sci Sports Exerc. 2007 May;39(5):756-63 – reference: 1681160 - Lancet. 1991 Sep 28;338(8770):774-8 – reference: 23151951 - MMWR Morb Mortal Wkly Rep. 2012 Nov 16;61(45):918-21 – reference: 22210578 - Diabetes Care. 2012 Feb;35(2):211-7 – reference: 8520716 - Ann Epidemiol. 1995 Jul;5(4):321-4 – reference: 21556140 - PLoS One. 2011;6(4):e18942 – reference: 19637289 - Hepatology. 2009 Oct;50(4):1105-12 – reference: 10993420 - Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504 – reference: 7752951 - Maturitas. 1995 Feb;21(2):137-45 – reference: 16404492 - Osteoporos Int. 2006;17(3):455-63 – reference: 19602539 - Diabetes Care. 2009 Aug;32(8):1404-10 – reference: 2052059 - N Engl J Med. 1991 Jul 18;325(3):147-52 – reference: 23456209 - Diabetologia. 2013 May;56(5):1012-20 – reference: 21233153 - BMJ. 2011;342:c7249 – reference: 20682057 - Int J Behav Nutr Phys Act. 2010 Aug 03;7:60 |
| SSID | ssj0005502 ssj0033214 |
| Score | 2.386304 |
| Snippet | Objective:
To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for... To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for type 2... OBJECTIVE: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for... International Journal of Obesity (2014) 38, 1089-1096; doi:10.1038/ijo.2013.224 Objective: To examine physical activity (PA) thresholds affecting glucose, insulin and lipid concentrations and body fat composition in high-risk patients for... |
| SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1089 |
| SubjectTerms | 692/699/2743/137/773 692/699/2743/393 692/700/2817 Biological and medical sciences Blood Glucose - metabolism Body mass index Body weight Care and treatment Cholesterol Development and progression Diabetes Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - prevention & control Epidemiology Exercise Exercise Therapy Female Finland Genetic aspects Glucose Glucose Tolerance Test Health aspects Health Promotion and Disease Prevention Homeostasis Humans Insulin Resistance Internal Medicine Intervention Intra-Abdominal Fat - metabolism Lifestyles Lipid Metabolism Lipids Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Metabolism Middle Aged Obesity Obesity - metabolism Obesity - prevention & control Original original-article Overweight Oxygen Oxygen uptake Physical fitness Physiological aspects Physiology Public Health Risk Reduction Behavior Sensors Surveys and Questionnaires Treatment Outcome Type 2 diabetes Walking Weight Loss |
| SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9RAEF9qBRGK6PlotNYRtH6w0Tw2m5zfytlSxBaRFvotZB-hkWvuuNyJ_lv-hc5sNjmjVfx2MLN7m2R2Hrszv2HsxViOw4InlCQVU0lOGPvjSEqfR7yM0FyIyBaJnZyK43P-4SK52GD7XS2MTdq3kJZWTXfZYW-rL1SpF8Zv0OTcYDcJtJ3keSIm64SOJOiRo2Lqv9NhIKKNT1zOexBng6kG1sjp5K150eD7KdvGFtd5nn8mUP52i2qN09Fddsd5lXDQPsc9tmHqEfPeV2YJe-CgP6dw2iHvj9itE3enPmJb7ckdtAVJIzZae5I42HZBb-6zHx8pioe5-6xA9RDUdgK0y6cxGuR3KKBtCwQNhsezBVJprsY04JLeAcN7cllR1vahsicaSJxW80rD5ezKzJCGDFDUGlk1Cl4DX6tG0dEZlMUS5wGCWPYpJx6alaRzpOYdfFoYSu45_AYWMBc-T84esPOjw7PJse_6PfgKg5qlL8cGTbaJdVaKwKAjIVDhmCLTosQoVKtAxjxQgShCyYMs1WXJizjIdJrxhJfI_ZBt1rPabDNIoqzQUikZRopHMpBSmVTLMBSqkGUQeOx1991z5cDQqSfHNLeX8nGWo5TkJCU5SonHXvbc8xYE5C98z0iE8raEtdcd-QG6RVGWoP702CvLQdoD_08VrggCV004XAPOnQEn7no1IO8OxLRfV0QAhgmn8Z3c5k4tNTn5x2GcxTT-eU-mqSnVrjazVcsjwjAV_-IR6LWjs5lFHnvUboX1AjCgxRhCeCwdbJKegQDNh5S6urTA5hy97ZSPPbbXbadfln7N-378v4xP2G38ydvEzR22uVyszFN0Jpdy1-qQn5xCchI priority: 102 providerName: Springer Nature |
| Title | Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT |
| URI | https://link.springer.com/article/10.1038/ijo.2013.224 https://www.ncbi.nlm.nih.gov/pubmed/24285336 https://www.proquest.com/docview/1551138331 https://www.proquest.com/docview/1551611761 https://www.proquest.com/docview/1622607582 https://pubmed.ncbi.nlm.nih.gov/PMC4125749 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgkxASQlBugVGMBOMBwmLHcVJe0CidJsSqadqkvUXxJVpQSUrTIvhb_ELOSdyUwNhLpcpfUyc5Phf7nO8Q8mKkRiwTESZJhViSw0J_xJXyBRc5B3MheVMkdjSVh2fi03l07jbcapdWudaJjaI2lcY98j007QzCqZC9n3_zsWsUnq66FhrXyTZSl2FKV3web1I8oqDjkgqxI8-aFRGsfuSy4IMw2Su-YBkgC99yLnr2yWnpW_OshieWt60uLvNF_02p_OtctTFXB3fIbedn0v1WMO6Sa7YcEO9jYZd0lzoy0Bmdrrn4B-TGkTtlH5DBxpcEcNMHvb5Hfn3GOJ7O3YulWBGBjSeocRk11lD1k2a0bQxEawiQqwWM4rVqW1OX9k4hwEenFaTtDS2aPQ0YnBXzwtCL6qutYAwANCsNQA2IXk2_F7XGzTOaZ0u4DkWSZR-z4mm9UriTVL-jxwuL6T2TH7ShzKUn49P75Oxgcjo-9F3HB19DWLP01ciC0bahSXIZWHAlJKgcmyVG5hCHGh2oUAQ6kBlTIkhik-ciC4PExImIRA7oB2SrrEr7iNCIJ5lRWivGteAqUErb2CjGpM5UHgQeeb1-z6l2dOjYlWOWNsfyYZKCVKQoFSlIhUdeduh5SwPyH9wzFJm0LWLttEe6D44RTyLQoB551SBQf8D_6cyVQcCskYmrh9zpIWHd697wsCeW3bw4UhhGAn-_ltPUKaY63SwjjzzvhvHSmGxX2mrVYiRjsbwKI8FvB3cz4R552Ir-ZgIQ0kIUIT0S9xZFB0BK8_5IWVw01OYC_O1YjDyyu14-f0z9kuf9-Op7fEJuAlK0CZs7ZGu5WNmn4EQu1bDRFPCZjNmQbH-YTI9P4NtYjn8Dl790Zw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFD5BSNTEGF1vVYQxEXzASjuddrsmxiCXgMCGEEh4q51LQ826u253Vf6UD_5Cz2mnu1aRN57n6-xs5-u5zJwLwMuO7PipCClIKqCUHD9wO1xKV3CRcVQXES-TxA670e6p-HgWns3BzzoXhsIqa5lYCmo9UHRGvk6q3Ud3KvDfD7-61DWKblfrFhoVLfbNxXd02Yp3e1u4vyuc72yfbO66tquAq9B0HruyY1AxmEDHWeQZVFcR0tqksY4y9HW08mQgPOVFqS-FF7d1lok08GLdjkUoMkTjvDdgQQToyszDwoft7tHxLKgk9KbVqwLqAVTXYUQ7I7Rx914Qr-efKfHQD95wLhoa0eqFO8O0wD3KquYal1m__wZx_nWTWyrInXtw11q2bKOi4n2YM_0WOFu5GbNVZsuP9li3rv7fgpuH9l6_Ba2Z9YrgsvN68QB-HdDJARtaKjHKwaBWF0zbGB6jmbxgKataEbECXfLBCEdprsIUzAbas5EpyExGfr9meXmKgoO9fJhrdj74YgY4hgCW9jVCNZK9YN_yQtFxHcvSMc7DqKyzS3H4rJhIOrsq3rKjkaGAou0frCzSy443Tx7C6bWw4RHM9wd98wRYyONUS6Wkz5Xg0pNSmbaWvh-pVGae58Bavc-JsgXYqQ9ILykDAYI4QVYkxIoEWeHAyhQ9rAqP_Ae3TJRJqrTZqbxKNtAU43GIMtuBVyWCJBb-nkpt4gWummp_NZCLDSRKGtUYXmrQcrouTkUTQ0HP1zxNrCgsktmH68CL6TBNTeF9fTOYVJjI99vRVZgIPQU0cGPuwOOK-rMFoBONfkvkQLvxUUwBVES9OdLPz8ti6gIt_LboOLBafz5_LP2S9_306v-4DLd2Tw4PkoO97v4zuI1PiSpcdBHmx6OJeY4m7FguWbnB4NN1i6rfMISvpg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6VIlVICEG4DKUdJFoewNRer48gIVQ1rVp6qEKtlDfjPawalSTECdC_xSO_jhl7nWAofevzjjcb-9s5dr-ZYexFV3b9TIREkgooJccP3C6X0hVc5BzNRcSrJLHDo2j3VHzoh_0F9qvJhSFaZaMTK0Wth4rOyDfItPsYTgX-Rm5pEce9nfejry51kKKb1qadRg2RfXPxHcO38t1eD7_1Guc72ydbu67tMOAqdKMnruwaNBIm0EkeeQZNV4QQN1mioxzjHq08GQhPeVHmS-Elsc5zkQVeouNEhCJHaZz3BrsZB6FPeyzux3N6SejN6lgF1A2oqciIHkdoGfhekGwUnykF0Q_ecC5attFaiNujrMSvlddtNi7zg_-lc_51p1uZyp277I71cWGzBuU9tmAGHeb0CjOBdbCFSM_hqOkD0GFLh_aGv8M6cz8Whase7OV99vOAzhBgZEEFlI1BTS9AWzaP0SAvIIO6KRGUGJwPxzhKc5WmBEu5h7EpyWFGpL-GojpPwcHzYlRoOBt-MUMcQwHIBhpFNcK-hG9FqejgDvJsgvMAFXh2iZEP5VTSKVb5Fo7HhqhF2z-gKtcLH7dOHrDTa8HCQ7Y4GA7MYwYhTzItlZI-V4JLT0plYi19P1KZzD3PYa-a75wqW4qdOoKcpxUlIEhSREVKqEgRFQ5bm0mP6hIk_5FbJcikdQLtTHOlm-iU8SRE7e2wl5UE6S78PZXZFAxcNVUBa0kutyRR56jW8EoLlrN1cSqfGAp6vsFpapVimc63sMOez4ZpaiL6DcxwWstEvh9HV8lEGDOgq5twhz2qoT9fAIbTGMFEDotbm2ImQOXU2yOD4qwqqy7Q149F12Hrzfb5Y-mXvO8nV__HVbaECio92Dvaf8pu4UOi5o0us8XJeGqeoS87kSuV0gD26bq11G80q7J2 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Light+physical+activity+determined+by+a+motion+sensor+decreases+insulin+resistance%2C+improves+lipid+homeostasis+and+reduces+visceral+fat+in+high-risk+subjects%3A+PreDiabEx+study+RCT&rft.jtitle=International+Journal+of+Obesity&rft.au=Jamsa%2C+T&rft.au=Ahola%2C+R&rft.au=Leppaluoto%2C+J&rft.au=Jokelainen%2C+J&rft.date=2014-08-01&rft.pub=Nature+Publishing+Group&rft.issn=0307-0565&rft.volume=38&rft.issue=8&rft.spage=1089&rft_id=info:doi/10.1038%2Fijo.2013.224&rft.externalDBID=n%2Fa&rft.externalDocID=A381285031 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |